Within-Subject Variation of Carcinoembryonic Antigen in Colorectal Cancer ' Application of Reference Change Values and Individual Reference Ranges to Patient Follow-Up

Clinical Chemistry and Laboratory Medicine

Volumn 35, Issue 6, 1997, Pages 453-458

  Mora, Josefina ^a   Queraltó, Josep M ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; FOLLOW UP; HUMAN; MALE; MODEL; PRIORITY JOURNAL; REFERENCE VALUE;

ADENOCARCINOMA; ADULT; AGED; ANALYSIS OF VARIANCE; BIOMETRY; BLOOD CHEMICAL ANALYSIS; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES;

EID: 0030872873     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1997.35.6.453     Document Type: Article

References (27)

1. Harris EK. Some theory of reference values. II Comparison of some statistical models of intraindividual variation in blood constituents. Clin Chem 1976: 22: 1343-50.
2. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry [review]. Crit Rev Clin Lab Sci 1989: 27: 409-437.
3. Boyd JC, Harris EK. Utility of reference change values for the monitoring of inpatient laboratory data. In: Zinder O, editor. Optimal use of the clinical laboratory. 5th Int. Meet. Clin. Lab. Organization and Management, Haifa August 26-29, 1985. Basel: Karger, 1986: 111-122.
4. Harris EK, Brown SS. Temporal changes in the concentration of serum constituents in healthy men. Distributions of within person variances and their relevance to the interpretation of differences between successive measurements. Ann Clin Biochem 1979: 16: 169-176.
5. Holzel WGE. Intra-individual variation of some analytes in serum of patients with chronic liver disease. Clin Chem 1987: 33: 1133-6.
6. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. J Am Med Assoc 1993: 270: 943-947.
7. Gion M: Ruggeri G, Marconato R, Rasella C, Nosadini A, La-ffanchini G, et al. Perioperatory kinetic evaluation of tumour markers in breast and colorectal carcinoma. J Nucl Med Allied Sci 1990: 34 Suppl 4: 9-12.
8. Kiang DT, Greenberg LJ, Kennedy BJ. Tumour marker kinetics in the monitoring of breast cancer. Cancer 1990: 65: 193-199.
9. Minton JP, Martin EW. The use of serial CEA determinations to predict recurrence of colon cancer and when to do a second-look operation. Cancer 1978: 42: 1422-7.
10. Winkel P, Lundbye-Christensen S, Christensen M. Analysis of serial measurements in clinical practice. Scand J Clin Lab Invest 1992: 52 Suppl 208: 105-121.
11. Ravry M, Moertel CG, Schutt AJ, Go VL. Usefulness of serial serum carcinoembryonic antigen (CEA) determinations during anticancer therapy or long-term follow-up of gastrointestinal carcinoma. Cancer 1974: 34: 1230-4.
12. Riesen W, Kessler AC, Ehrhardt V. Individual variations of carcinoembryonic antigen (CEA) in serum of healthy subjects. Clin Chem 1987: 33: 2123.
13. Browning MCK. Biological variation of the breast tumour marker CA 15.3: implications for necessary standards of performance and the interpretation of results. Ann Clin Biochem 1987: 24 Suppl. 1: 35-38.
14. Browning MCK, McFarlane MP, Morobin JM, Preece PE, Wood RAB. Evaluation of the comparative clinical utility of CA 15.3 and mucinous carcinoma-associated antigen (MCA) in the management of breast carcinoma. Ann Clin Biochem 1988: 25: 54-57.
15. Panteghini M, Pagani F, Bonora R. Pre-analytical and biological variability of prostatic acid phosphatase and prostate-specific antigen in serum from patients with prostatic pathology. Eur J Clin Chem Clin Biochem 1992: 30: 135-139.
16. Gion M, Cappelli G, Mione R, Vignati G, Fortunato A, Saracchini S, et al. Variability of tumour markers in the follow-up in patients radically resected for breast cancer. Tumour Biol 1993: 14: 325-333.
17. Söletormos G, Schioler V, Nielsen D, Skovsgaard T, Domber-nowsky P. Interpretation of results for tumour marker on the basis of analytical imprecision and biological variation. Clin Chem 1993: 39: 2077-83.
18. Hölzel WGE, Beer R, Deschner W, Griesmacher A, Müller MM. Individual reference ranges of CA 15-3, MCA and CEA in recurrence of breast cancer. Scand J Clin Lab Invest 1995: 55 Suppl 221: 93-101.
19. Cohen AM, Minsky BD, Schilsky RL. Colon cancer. In: De-Vita VT, Heilman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 4th ed. Philadelphia: J. B. Lippincott, 1993: 929-977.
20. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981: 47: 207-214.
21. Schlein BR, Lavin PT, Hayden CL. Using an autoregressive model to detect departures from steady states in unequally spaced tumour biomarkers data. Stat Med 1992: 11: 515-532.
22. Harris EK, Boyd JC. Statistical bases of reference values in laboratory medicine. New York, NY: Marcel Dekker Inc., 1995: 221-258.
23. Healy MJR. Outliers in clinical chemistry quality control schemes. Clin Chem 1979: 25: 675-677.
24. Queraltó JM, Boyd JC, Harris EK. On the calculation of reference change values, with examples from a long-term study. Clin Chem 1993: 39: 1398-403.
25. Harris EK. Distinguishing physiologic variation from analytic variation. J Chron Dis 1970: 469-480.
26. Box GEP, Jenkins GM. Time series analysis, forecasting and control. San Francisco: Holden Day, 1970: 129.
27. Deijter SW, Martin JS, McPherson RA, Lynch JH. Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation. Urology 1988: 32: 288-292.